Aug 27, 2020Health Sciences0 likes Auto-indexed

Clinical Validation of Fresh Drooled Whole Saliva and GeneFiX for SARS-CoV-2 Diagnosis

Keywords:Fresh Drooled Whole SalivaGeneFiXSARS-CoV-2COVID-19CoronavirusdiagnosisClinicalValidationSARS-CoV-2 diagnosisSalivaPCR-based methods
Poster thumbnail

Description

introduction WHO reference standard for SARS-CoV-2 diagnosis is RT-PCR using DNA extracted from nasopharyngeal swab (NPS) or oropharyngeal swab (OPS) . There is limited vigorous evidence for the use of saliva in SARS-CoV-2 diagnosis . Aim To validate the diagnostic accuracy of whole saliva-derived DNA for PCR-based methods in the detection of SARS-CoV-2. Methodology 12 adults comprising of 7 RT-PCR confirmed COVID-19 subjects and 5 Person Under Investigation (PUI) as negative controls were recruited. Early morning fresh drooled saliva was collected into: a. Sterile plastic container (2mls) b. GeneFiX saliva container (2mls). NPS taken from each subject in the same setting for diagnostic comparison (Figure 1). Samples were triple packaged and processed for viral titres within 6 hours at an accredited laboratory. Results The mean age was 31.83 ± 10.37 years. Half were asymptomatic and almost all (91.7%) had significant travelling history. Median days of illness was 0.5 days (IQR=5) and all were recruited within a median of 3 days (IQR=11) of admission (Table 1). Margin of difference in Ct. values between the two saliva collection methods was small (Table 2). There was good concordance among the 3 types of samples when taken during the early course of illness (Table 3). However, NPS gave a lower Ct. value between the three collection methods in both E and N2 genes. Discussion / Conclusion RT-PCR diagnostic test for SARS-CoV-2 using fresh drooled saliva is both sensitive and specific as the virus is also shed in saliva. Saliva can serve as an alternative specimen for detecting SARS-CoV-2. Further validation using larger samples of COVID-19 subjects is necessary to support fresh saliva as a preferred non-invasive standard for COVID-19.

Conference Information

Poster C-22

Year:2020

Identifiers

Authors

Alif Adlan Mohd Thabit

Medical Department, Sungai Buloh Hospita

ORCID: https://orcid.org/0000-0001-5473-0955

Kalaiarasu M. Peariasamy

Clinical Research Centre, Sungai Buloh Hospita

Nelson Nheu

Gribbles Pathology (M) Sdn. Bhd.

Kuan Pei Xuan

Clinical Research Centre, Sungai Buloh Hospita

Denisa Khoo

Paediatric Dental Department, Sungai Buloh Hospital

Suresh Kumar Chidambaram

Medical Department, Sungai Buloh Hospital

Afifah Haji Hassan

Pathology Department, Sungai Buloh Hospital

Muhamad Afiq Mu'iz bin Arifin

Medical Department, Sungai Buloh Hospital

Amira Naziffa Shamsuddin

Medical Department, Sungai Buloh Hospital

Mohd Asri Yamim

Pathology Department, Sungai Buloh Hospital

Camille Cyncynatus

Gribbles Pathology (M) Sdn. Bhd.

Harvinder Kaur Lakhbeer Singh

Gribbles Pathology (M) Sdn. Bhd.

Ganeswrie Rajasekaram

Gribbles Pathology (M) Sdn. Bhd.

Martin Giddy

Gribbles Pathology (M) Sdn. Bhd.

Additional Information

LanguageEnglish
Formatapplication/pdf
Version1
License
Creative Commons Attribution 4.0 International
Indexed fromZenodo